The approved product has an estimated market size of around US$ 606 million for the twelve months ending June 2022, according to IQVIA.
Results consistent with previous trials, reinforcing benefit of Daiichi Sankyo and AstraZeneca’s ENHERTU in previously treated patients
The total budget of Rs. 3119.46 crores has been allocated/ released as a central share to States/UTs since the inception of the scheme and they have reported an expenditure of Rs. 2290.20 crores.
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
ANI’s Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.
The Ayushman Bharat Digital Mission (ABDM) aims to replicate this success in healthcare delivery by building an equitable, accessible and inclusive ecosystem
Company hires life science veteran Jessica Cao to join management team
The second phase of the orientation workshop is being organized to provide in-depth knowledge to the state officials on core building blocks of ABDM
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
The ABDM public dashboard is a one-stop solution for information on the mission’s progress up to state/UT level
Subscribe To Our Newsletter & Stay Updated
